communityacquir
pneumonia
cap
one
clinic
import
diseas
adult
affect
per
adult
per
year
fifti
eighti
percent
patient
cap
treat
ambulatori
basi
howev
knowledg
clinic
manifest
outcom
cap
come
studi
among
patient
requir
admiss
hospit
cap
manag
guidelin
influenc
cap
etiolog
studi
current
avail
evid
randomizedcontrol
trial
rct
scan
insuffici
make
evidencebas
recommend
choic
antibiot
treatment
cap
ambulatori
patient
although
cap
guidelin
acknowledg
respiratori
virus
caus
pneumonia
recommend
made
regard
manag
viral
pneumonia
august
juli
consecut
adult
adolesc
year
age
seen
fever
clinic
requir
hospit
prospect
enrol
surveil
studi
none
patient
immunocompromis
patient
hiv
infect
neutropenia
receiv
immunosuppress
chemotherapi
exclud
addit
patient
nurs
home
patient
admit
hospit
within
last
day
also
exclud
first
clinic
encount
patient
followedup
telephon
within
day
symptom
sign
record
daili
patient
suspect
cap
chest
xray
cxr
one
patient
normal
cxr
posit
comput
tomographi
ct
scan
pneumonia
sever
index
psi
use
assess
sever
ill
throat
swab
collect
mycoplasma
pneumonia
cultur
polymeras
chain
reaction
pcr
assay
sputum
throat
swab
screen
presenc
respiratori
syncyti
viru
rsv
influenza
viru
ifv
b
c
parainfluenza
viru
piv
human
rhinovirus
hrv
enteroviru
ev
human
coronaviru
hcov
human
metapneumoviru
hmpv
adenoviru
adv
previous
report
microbi
etiolog
classifi
definit
presumpt
unknown
bacteria
consid
definit
caus
agent
isol
blood
pleural
fluid
cultur
pneumonia
isol
consid
definit
pathogen
legionella
pneumophila
streptococcu
pneumonia
consid
definit
agent
urinari
antigen
test
posit
bacteri
pathogen
consid
presumpt
respiratori
pathogen
isol
purul
sputum
defin
adequ
qualiti
sputum
sampl
leukocyt
epitheli
cell
per
magnif
field
presenc
nucleic
acid
pneumonia
respiratori
virus
sputum
throat
swab
molecular
method
consid
presumpt
comparison
clinic
characterist
clinic
outcom
conduct
patient
known
caus
pathogen
without
use
unpair
student
ttest
test
chisquar
test
spss
window
data
adult
cap
outpati
avail
analysi
convalesc
serum
sampl
obtain
patient
overal
median
age
patient
year
rang
year
male
mild
cap
psi
microbiolog
diagnosi
establish
patient
common
pathogen
pneumonia
follow
respiratori
virus
pneumonia
influenza
viru
ifva
common
respiratori
viru
identifi
follow
parainfluenza
viru
piv
adenoviru
adv
human
metapneumoviru
hmpv
presenc
two
three
pathogen
detect
ten
outpati
five
patient
coinfect
pneumonia
respiratori
viru
four
coinfect
bacteria
viru
one
patient
three
pathogen
haemophilu
influenza
pneumonia
ifva
two
diagnos
pulmonari
tuberculosi
posit
cultur
mycobacterium
tuberculosi
sputum
tabl
none
patient
test
posit
l
pneumonia
urin
antigen
test
urinari
antigen
test
posit
pneumonia
four
patient
two
sputum
one
blood
cultur
posit
pneumonia
sputum
cultur
neg
patient
mycoplasma
infect
younger
bacteri
viral
infect
p
lower
psi
score
p
less
like
comorbid
p
less
like
adequ
sputum
gram
stain
cultur
p
patient
bacteri
infect
like
underli
diseas
p
higher
leukocyt
count
p
patient
viral
infect
older
like
poorli
defin
nodul
cxr
ct
scan
p
patient
mycoplasma
infect
longer
total
durat
fever
bacteri
infect
p
pathogen
found
p
patient
bacteri
infect
longer
durat
onset
ill
resolut
respiratori
symptom
mycoplasma
infect
p
pathogen
found
p
patient
bacteri
infect
also
longer
durat
respiratori
symptom
initi
antibiot
pathogen
found
p
tabl
signific
differ
outcom
patient
bacteri
infect
accord
initi
prescript
antibiot
macrolid
vs
quinolon
p
among
patient
infect
mycoplasma
quinolon
initi
prescript
shorter
durat
fever
initi
antibiot
patient
macrolid
macrolid
p
tabl
main
find
prospect
cohort
studi
pneumonia
frequent
pathogen
found
ambulatori
adult
cap
patient
follow
respiratori
virus
pneumonia
patient
differ
caus
pathogen
differ
clinic
featur
patient
mycoplasma
infect
younger
lower
psi
score
less
like
present
purul
sputum
patient
bacteri
infect
like
underli
diseas
higher
leukocyt
count
patient
viral
infect
like
poorli
defin
nodul
cxr
ct
quinolon
seem
better
macrolid
macrolid
resolut
fever
pneumonia
pneumonia
littl
attent
paid
etiolog
clinic
outcom
ambulatori
adult
cap
patient
similar
report
roux
et
al
johnston
et
al
demonstr
signific
potenti
contribut
respiratori
virus
patient
present
pneumonia
viral
pneumonia
ifva
n
piv
n
adv
n
hmpv
n
commonli
seen
also
found
clinic
featur
outcom
viral
cap
compar
bacteri
atyp
bacteri
pathogen
except
patient
viral
infect
older
like
poorli
defin
nodul
cxr
ct
scan
tabl
wellaccept
standard
everi
cap
patient
receiv
antibacteri
agent
base
find
suggest
bacteria
atyp
pathogen
detect
antibacteri
agent
routin
given
clinic
trial
indic
confirm
suggest
select
target
patient
popul
antibacteri
agent
safe
withheld
base
prospect
data
patient
cap
capnetz
pneumonia
pneumonia
found
significantli
often
younger
patient
less
comorbid
present
less
sever
diseas
show
lower
inflammatori
respons
term
leukocyt
count
creactiv
protein
crp
valu
better
outcom
also
demonstr
compar
bacteri
viral
pneumonia
cap
patient
infect
pneumonia
younger
lower
psi
score
less
like
adequ
sputum
gram
stain
cultur
tabl
japanes
respiratori
societi
jr
guidelin
cap
includ
five
paramet
differenti
atyp
pneumonia
bacteri
pneumonia
pneumonia
paramet
persist
cough
limit
auscultatori
find
chest
examin
minim
sputum
product
peripher
white
blood
cell
count
nonsever
comorbid
ill
older
cap
clinic
evalu
studi
efficaci
usual
defin
composit
endpoint
clinic
cure
pneumoniaassoci
complic
mortal
ambulatori
cap
patient
total
durat
fever
day
pneumoniaassoci
complic
death
evalu
outcom
variou
pathogen
use
surrog
endpoint
rapid
resolut
clinic
manifest
pneumonia
fever
respiratori
tract
symptom
found
although
patient
cap
caus
pneumonia
less
sever
ill
measur
psi
longer
durat
fever
patient
infect
common
bacteri
pathogen
bacteri
pneumonia
clinic
outcom
compar
patient
treat
andor
macrolid
respiratori
quinolon
pneumonia
quinolon
appear
superior
efficaci
compar
resolut
fever
tabl
trend
favor
quinolon
treatment
cap
caus
pneumonia
explain
high
preval
macrolid
resist
pneumonia
isol
adult
adolesc
patient
respiratori
tract
infect
serolog
method
frequent
use
diagnosi
pneumonia
infect
reliabl
diagnosi
pneumonia
infect
still
made
basi
singl
acutephas
sera
pair
sera
obtain
acut
convalesc
phase
order
demonstr
rise
antibodi
titer
fourfold
increas
thought
signific
cold
agglutinin
igm
antibodi
may
appear
second
week
ill
detect
titer
greater
patient
pneumonia
due
pneumonia
test
nonspecif
render
histor
valu
clinic
util
pcr
diagnosi
alreadi
avail
center
becom
increasingli
avail
like
replac
serodiagnosi
longer
term
realtim
pcr
high
sensit
high
specif
detect
pathogen
dna
even
damag
empir
administr
antibiot
sensit
specif
realtim
pcr
higher
serolog
assay
pneumonia
almost
pcrposit
case
also
confirm
serolog
avail
pcr
sputum
lower
respiratori
tract
sampl
method
choic
diagnosi
pneumonia
absenc
sputum
throat
swab
pneumonia
pcr
recommend
limit
studi
includ
follow
singlecent
studi
case
one
year
conclus
effect
antibiot
made
care
number
patient
subgroup
small
statist
signific
mean
necessarili
clinic
relev
cultur
legionella
spp
pair
serolog
perform
studi
conclus
found
pneumonia
respiratori
virus
ifva
piv
adv
hmpv
frequent
pathogen
found
ambulatori
adult
cap
patient
also
observ
quinolon
better
macrolid
macrolid
resolut
fever
pneumonia
pneumonia
